On Demand: Better Together: How Pharmacy and Cardiology Partnerships Elevate the Transthyretin Amyloidosis Care Delivery Journey-Webinar Recording

Video Transcription

Video Summary

MedAxiom hosted a webinar sponsored by Alnylam titled “Better Together: How Pharmacy and Cardiology Partnerships Elevate the ATTR Care Delivery Journey.” Ginger Biesbrod (Advocate Health) opened by contrasting historical “supportive care” for amyloidosis with today’s expanding treatment options, emphasizing that success now depends on identifying patients earlier and ensuring smooth access to therapy.<br /><br />ATTR amyloidosis remains underdiagnosed and undertreated: an estimated 150,000 U.S. cardiac amyloid patients exist, but only ~60,000 are diagnosed and just 15,000–25,000 are appropriately treated. Survey findings with Becker’s Healthcare highlighted fragmented patient identification, lack of standardized workflows, and limited cross-specialty coordination among cardiology, neurology, and pharmacy.<br /><br />Panelists Jorge Garcia and Bhavesh Shah described how embedded pharmacists support screening, referrals, medication optimization, adherence, and lab/medication management via collaborative practice agreements. They discussed using data tools and future AI approaches to “hunt” for at-risk patients within EHRs. Operationally, they stressed centralized intake and benefits investigation, and careful site-of-care planning (HOPD, infusion centers, home/alternate sites) to avoid delays and denials. Buy-and-bill was framed as improving safety, continuity, patient satisfaction, and financial performance when paired with strong revenue-cycle and managed-care collaboration. Metrics tracked include adherence, tolerability, readmissions/ED visits, and disease trajectory.

Keywords

transthyretin amyloidosis

ATTR cardiomyopathy

pharmacy-cardiology partnership

embedded clinical pharmacists

patient identification

EHR-based screening

AI risk stratification

prior authorization and benefits investigation

infusion services and buy-and-bill

ATTR amyloidosis

cardiac amyloidosis

embedded clinical pharmacist

early patient identification

EHR screening and AI tools

centralized intake and benefits investigation

site-of-care planning (HOPD/infusion/home)

buy-and-bill revenue cycle management